Meanwhile, as a positive control, rosiglitazone, a thiazolidinedione-type medicine for treating diabetes, also promoted the glucose consumption of the cells in the presence or absence of insulin (Groups 7 and 8). The gene discussed is INS; the disease is diabetes mellitus.